李旭日

李旭日.jpg


李旭日教授为国际著名血管生物学家,中组部“千人计划”专家,广东省引进“创新领军人才”,中山大学引进学科领军人才,中山大学中山眼科中心眼科学国家重点实验室副主任,亚太血管生物学协会(APVBO)创始人,北美血管生物学协会(NAVBO)委员,中山大学学术委员会委员,Vascular CellCardiovascular & Hematological Disorders-Drug Targets编委委员。2005-2012年任美国国立卫生院眼科研究所(NIH/NEI)任研究室主任,首席科学家(Principal Investigator)2012年率团队回国,全职加入中山大学中山眼科中心。

李旭日教授长期从事血管神经生物学研究,在血管神经生物学领域取得国际公认的成就,首次发现了两个重要生长因子(PDGF-C PDGF-D)并揭示了其功能和机制。李旭日教授承担国内外科研项目10多项,科研总经费达1300多万美元,获国际发明专利5项,参加60多次国际重要学术会议,特邀报告45次,组织/共同组织10次重要国际学术会议,担任21个国际著名学术期刊审稿人,为国内外多项科研基金的评审专家。在ScienceNature Cell BiologyJ Clin InvestJ Exp MedPNASCancer ResCell Rep等国际著名期刊发表SCI收录论文76篇,总影响因子达680多分,被引用6200多次。被包括NatureNat MedNature Reviews等顶级杂志引用,其中单篇引用次数超过750次,获Nat Cell BiolNew Engl J MedATVB等的专栏报道。

 

Dr. Xuri Li is a Professor and Scientific Director of the State Key Laboratory of Ophthalmology at the Zhongshan Ophthalmic Center (ZOC), Sun Yat-sen University in Guangzhou, China. Dr. Li is the founder of Asia Pacific Vascular Biology Organization (APVBO). Dr. Li is also a special expert of the Chinese governmental 1000-Program, and a leading expert of Guangdong province. Before joining the ZOC in 2012, Dr. Li served as a Principal Investigator at the National Institutes of Health, National Eye Institute in the US during 2005-2012.

Dr. Xuri Li has been long engaged in the study of neurovascular biology and her achievement in the field has been internationally recognized. Discovered two novel growth factors (PDGF-C and PDGF-D), Dr. Li has also revealed their functions and mechanisms. Dr. Li has undertaken more than 10 scientific research projects with a total amount of 13 million U.S. dollars and 5 international patents. Dr. Li has published 76 SCI articles in international top journals, such as Science, Nature Cell Biology, J Clin Invest, J Exp Med, PNAS, Cancer Res, Cell Rep (Total IF > 680, Total citation > 6200). Dr. Li is also on the editorial boards of several international vascular biology journals.